Serious infections during anti-TNFα treatment in rheumatoid arthritis patients-Reference-Cited by-同舟云学术

Serious infections during anti-TNFα treatment in rheumatoid arthritis patients

Published:2009-01 Issue:3 Volume:8 Page:266-273
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Favalli Ennio Giulio,Desiati Francesca,Atzeni Fabiola,Sarzi-Puttini Piercarlo,Caporali Roberto,Pallavicini Francesca Bobbio,Gorla Roberto,Filippini Matteo,Marchesoni Antonio

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference36 articles.

1. Treatment of rheumatoid arthritis with a recombinant human tumour necrosis factor (p75)-Fc fusion protein;Moreland;N Engl J Med,1997

2. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial;Maini;Lancet,1999

3. Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study;Weinblatt;Ann Rheum Dis,2006

4. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial;Klareskog;Lancet,2004

5. Infliximab and methotrexate in the treatment of rheumatoid arthritis;Lipsky;N Engl J Med,2000

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UK;Infectious Diseases and Therapy;2024-04-24

2. Infections in Biological and Targeted Synthetic Drug Use in Rheumatoid Arthritis: Where do We Stand? A Scoping Review and Meta-analysis;Rheumatology and Therapy;2023-06-26

3. Real-World Incidence and Determinants of Infection in Patients With Rheumatoid Arthritis Treated With Golimumab After a Median Follow-Up Time of 27 Months;The Journal of Rheumatology;2023-06-01

4. Infections in biological and targeted synthetic drug use in rheumatoid arthritis: where do we stand? A scoping review and meta-analysis;2023-03-09

5. Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review;Frontiers in Pharmacology;2023-01-20